Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

The document concludes that the new expert system can assess the risk of PCOS effectively despite uncertainties in diagnosis.

CRPS type I is a complex pain condition with no proven cure, requiring personalized treatment.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Senior residency helps dermatology graduates develop skills and plan their careers.

Early diagnosis and treatment are crucial for skin emergencies and drug reactions.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

A new portable microscope can effectively monitor skin wound healing in real-time.

AMT® shows promise as a safe and effective treatment for early-stage knee osteoarthritis.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Augmented virtual reality can help manage chronic skin conditions.

A multidisciplinary approach is crucial for managing Silver-Russell syndrome effectively.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

Neck burn scar contracture recurrence is more likely with larger neck defects, and closer follow-up can help detect it sooner.

The conclusion about the value of ABHRS certification cannot be determined from the text provided.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

The combination therapy was effective and well-tolerated, especially in young patients.

No treatment is clearly better for central serous chorioretinopathy, and more research is needed.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.